Charles River Laboratories Announces Third-Quarter 2016 Results from Continuing Operations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
Charles River Laboratories (CRL) Tops Q3 EPS by 5c; Narrows Outlook
November 2, 2016 7:05 AM EDTCharles River Laboratories (NYSE: CRL) reported Q3 EPS of $1.18, $0.05 better than the analyst estimate of $1.13. Revenue for the quarter came in at $425.7 million versus the consensus estimate of $434.42 million.
GUIDANCE:
Charles River Laboratories sees FY2016 EPS of $4.44-$4.49, versus... More
